| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,322 |
14,521 |
$530K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14,310 |
12,979 |
$480K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
21,261 |
10,902 |
$258K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,652 |
4,397 |
$233K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15,052 |
13,688 |
$169K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,525 |
3,314 |
$138K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,048 |
1,027 |
$63K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,315 |
3,037 |
$32K |
| 87428 |
|
509 |
424 |
$28K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
474 |
448 |
$18K |
| 87807 |
|
1,444 |
1,370 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
917 |
843 |
$11K |
| 71046 |
Radiologic examination, chest; 2 views |
211 |
199 |
$3K |
| 81003 |
|
1,405 |
1,310 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,374 |
2,179 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
178 |
164 |
$2K |
| 99000 |
|
66 |
63 |
$604.80 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
466 |
421 |
$492.32 |
| 74018 |
|
28 |
26 |
$478.62 |
| 86328 |
|
44 |
38 |
$452.16 |
| 81025 |
|
38 |
38 |
$212.19 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
31 |
27 |
$134.93 |
| 94760 |
|
19 |
19 |
$11.65 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
64 |
63 |
$6.76 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
26 |
26 |
$0.75 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
13 |
13 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
91 |
90 |
$0.00 |
| 76140 |
|
38 |
36 |
$0.00 |